Drägerwerk AG & Co. KGaA (XETRA:DRW8) — Market Cap & Net Worth
Market Cap & Net Worth: Drägerwerk AG & Co. KGaA (DRW8)
Drägerwerk AG & Co. KGaA (XETRA:DRW8) has a market capitalization of $826.72 Million (€707.14 Million) as of June 15, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #9881 globally and #1200 in its home market, demonstrating a -3.60% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Drägerwerk AG & Co. KGaA's stock price €69.60 by its total outstanding shares 10160000 (10.16 Million). Review total liabilities of Drägerwerk AG & Co. KGaA to assess the company's total debt and financial obligations.
Drägerwerk AG & Co. KGaA Market Cap History: 2015 to 2026
Drägerwerk AG & Co. KGaA's market capitalization history from 2015 to 2026. Data shows growth from $670.05 Million to $826.72 Million (2.55% CAGR).
Drägerwerk AG & Co. KGaA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Drägerwerk AG & Co. KGaA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.15x
Drägerwerk AG & Co. KGaA's market cap is 0.15 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.93x
Drägerwerk AG & Co. KGaA's market cap is 3.93 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $670.05 Million | $2.61 Billion | $33.58 Million | 0.26x | 19.96x |
| 2016 | $725.14 Million | $2.52 Billion | $82.08 Million | 0.29x | 8.83x |
| 2017 | $681.53 Million | $2.57 Billion | $98.47 Million | 0.26x | 6.92x |
| 2018 | $463.26 Million | $2.60 Billion | $34.35 Million | 0.18x | 13.48x |
| 2019 | $446.66 Million | $2.78 Billion | $33.35 Million | 0.16x | 13.39x |
| 2020 | $677.29 Million | $3.41 Billion | $250.16 Million | 0.20x | 2.71x |
| 2021 | $613.80 Million | $3.33 Billion | $154.23 Million | 0.18x | 3.98x |
| 2022 | $413.11 Million | $3.05 Billion | -$64.56 Million | 0.14x | N/A |
| 2023 | $510.33 Million | $3.34 Billion | $93.72 Million | 0.15x | 5.45x |
| 2024 | $489.38 Million | $3.37 Billion | $124.41 Million | 0.15x | 3.93x |
Competitor Companies of DRW8 by Market Capitalization
Companies near Drägerwerk AG & Co. KGaA in the global market cap rankings as of June 15, 2026.
Key companies related to Drägerwerk AG & Co. KGaA by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #150 globally with a market cap of $153.33 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #200 globally with a market cap of $119.48 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #236 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #246 globally with a market cap of $102.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #150 | Abbott Laboratories | NYSE:ABT | $153.33 Billion | $88.18 |
| #200 | Stryker Corporation | NYSE:SYK | $119.48 Billion | $312.20 |
| #236 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #246 | Medtronic PLC | NYSE:MDT | $102.97 Billion | $80.20 |
Drägerwerk AG & Co. KGaA Historical Marketcap From 2015 to 2026
Between 2015 and today, Drägerwerk AG & Co. KGaA's market cap moved from $670.05 Million to $ 826.72 Million, with a yearly change of 2.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €826.72 Million | +23.40% |
| 2025 | €669.93 Million | +36.89% |
| 2024 | €489.38 Million | -4.11% |
| 2023 | €510.33 Million | +23.53% |
| 2022 | €413.11 Million | -32.70% |
| 2021 | €613.80 Million | -9.37% |
| 2020 | €677.29 Million | +51.64% |
| 2019 | €446.66 Million | -3.58% |
| 2018 | €463.26 Million | -32.03% |
| 2017 | €681.53 Million | -6.01% |
| 2016 | €725.14 Million | +8.22% |
| 2015 | €670.05 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 15th, 2026 the market cap of Drägerwerk AG & Co. KGaA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $826.72 Million USD |
| MoneyControl | $826.72 Million USD |
| MarketWatch | $826.72 Million USD |
| marketcap.company | $826.72 Million USD |
| Reuters | $826.72 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas m… Read more